GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Beneish M-Score

RBC Bioscience (ROCO:6848) Beneish M-Score : -2.58 (As of May. 25, 2024)


View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.58 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for RBC Bioscience's Beneish M-Score or its related term are showing as below:

ROCO:6848' s Beneish M-Score Range Over the Past 10 Years
Min: -3.04   Med: -2.58   Max: -0.34
Current: -2.58

During the past 7 years, the highest Beneish M-Score of RBC Bioscience was -0.34. The lowest was -3.04. And the median was -2.58.


RBC Bioscience Beneish M-Score Historical Data

The historical data trend for RBC Bioscience's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience Beneish M-Score Chart

RBC Bioscience Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial -3.04 -0.34 -2.62 -0.85 -2.58

RBC Bioscience Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.62 - -0.85 - -2.58

Competitive Comparison of RBC Bioscience's Beneish M-Score

For the Biotechnology subindustry, RBC Bioscience's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RBC Bioscience's Beneish M-Score Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RBC Bioscience's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where RBC Bioscience's Beneish M-Score falls into.



RBC Bioscience Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of RBC Bioscience for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9063+0.528 * 0.9933+0.404 * 1.0914+0.892 * 0.9918+0.115 * 0.9858
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.9635+4.679 * -0.008992-0.327 * 0.9932
=-2.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Dec23) TTM:Last Year (Dec22) TTM:
Total Receivables was NT$23.0 Mil.
Revenue was NT$172.5 Mil.
Gross Profit was NT$72.9 Mil.
Total Current Assets was NT$140.2 Mil.
Total Assets was NT$753.8 Mil.
Property, Plant and Equipment(Net PPE) was NT$533.5 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$19.2 Mil.
Selling, General, & Admin. Expense(SGA) was NT$47.4 Mil.
Total Current Liabilities was NT$99.8 Mil.
Long-Term Debt & Capital Lease Obligation was NT$412.6 Mil.
Net Income was NT$6.4 Mil.
Gross Profit was NT$0.0 Mil.
Cash Flow from Operations was NT$13.2 Mil.
Total Receivables was NT$25.6 Mil.
Revenue was NT$173.9 Mil.
Gross Profit was NT$73.0 Mil.
Total Current Assets was NT$156.9 Mil.
Total Assets was NT$790.5 Mil.
Property, Plant and Equipment(Net PPE) was NT$556.7 Mil.
Depreciation, Depletion and Amortization(DDA) was NT$19.7 Mil.
Selling, General, & Admin. Expense(SGA) was NT$49.6 Mil.
Total Current Liabilities was NT$123.7 Mil.
Long-Term Debt & Capital Lease Obligation was NT$417.3 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(23.002 / 172.467) / (25.59 / 173.891)
=0.13337 / 0.147161
=0.9063

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(73.006 / 173.891) / (72.895 / 172.467)
=0.419838 / 0.422661
=0.9933

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (140.213 + 533.543) / 753.79) / (1 - (156.898 + 556.738) / 790.546)
=0.106175 / 0.097287
=1.0914

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=172.467 / 173.891
=0.9918

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(19.737 / (19.737 + 556.738)) / (19.197 / (19.197 + 533.543))
=0.034237 / 0.034731
=0.9858

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(47.409 / 172.467) / (49.612 / 173.891)
=0.274887 / 0.285305
=0.9635

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((412.598 + 99.765) / 753.79) / ((417.287 + 123.735) / 790.546)
=0.679716 / 0.684365
=0.9932

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(6.43 - 0 - 13.208) / 753.79
=-0.008992

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

RBC Bioscience has a M-score of -2.58 suggests that the company is unlikely to be a manipulator.


RBC Bioscience Beneish M-Score Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


RBC Bioscience (ROCO:6848) Business Description

Traded in Other Exchanges
N/A
Address
Lane 235, Baoqiao Road, 3rd Floor, No. 132, New Taipei City, TWN, 23145
RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.

RBC Bioscience (ROCO:6848) Headlines

No Headlines